Abiopharma

🔍 Partners Group Private Equity Fund, LLC (Executive)

Company: Life Time Group Holdings, Inc. (LTH)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 372,420 shares of Common Stock at $28.6 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 3,348,080.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 169,699 shares of Common Stock at $28.6 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 3,178,381.00 | transaction_form_type: 4 | Footnotes: F4, F5, F3

Footnotes:

• F1: Represents 196,114 shares sold by Partners Group Private Equity Fund, LLC ("PG PE Fund"), 431 shares sold by Partners Group Private Equity II, LLC ("PG PE II"), 13,534 shares sold by Partners Group Access 83 PF LP ("PG Access 83"), and 162,341 shares sold by Partners Group Series Access II, LLC, Series 61 ("PG Series 61") in in each case in a private transaction exempt from registration under the Securities Act of 1933.
• F2: 1,763,070 of such shares of Common Stock are directly held by PG PE Fund, 3,875 of such shares are directly held by PG PE II, 121,675 of such shares are directly held by PG Access 83 and 1,459,460 of such shares are directly held by PG Series 61.
• F3: The investment manager of PG Master Fund is Partners Group (USA) Inc. ("PG USA"). PG USA, PG PE II, PG Access 83 and PG Series 61 are indirectly controlled by Partners Group Holding AG. Each of PG PE Fund, PG PE II, PG Access 83 and PG Series 61 disclaims beneficial ownership of any securities that it does not directly beneficially own, except to the extent of its pecuniary interest, if any, therein.
• F4: Represents 92,732 shares sold by PG PE Fund, 204 shares sold by PG PE II, and 76,763 shares sold by PG Series 61 in each case in a private transaction to the Issuer.
• F5: 1,670,338 of such shares of Common Stock are directly held by PG PE Fund, 3,671 of such shares are held directly by PG PE II, 121,675 of such shares are directly held by PG Access 83, and 1,382,697 of such shares are directly held by PG Series 61.
• REMARKS: The Reporting Persons may be deemed to be members of a "group" for the purposes of the Securities Exchange Act of 1934 by virtue of being parties to the Life Time Group Holdings, Inc. Third Amended and Restated Stockholders Agreement (the "Stockholders Agreement"). Each Reporting Person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by such Reporting Person. This report shall not be deemed an admission that the Reporting Persons are members of a group or the beneficial owners of any securities not directly owned by the Reporting Persons. The Reporting Persons disclaim beneficial ownership of any such securities except to the extent of their pecuniary interest, if any, therein. Pursuant to the Stockholders Agreement, Mr. Andres Small, an employee of an affiliate of the Reporting Persons, serves on the Issuer's board of directors as the Reporting Persons' representative.